FILE PHOTO: Vials of Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weigh loss, are ...

Although data for Eli Lilly’s orforglipron may have disappointed investors earlier this month, a new release of Phase III ...

The obesity-care market is largely dominated by just two players: Eli Lilly and Novo Nordisk. 10 stocks we like better than ...

New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

Shares of Chugai Pharmaceutical (OTCPK:CHGCY) closed ~6% higher on Wednesday after Eli Lilly (NYSE:LLY) announced that its ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose ...

Eli Lilly (LLY) stock is up as the firm's oral weight loss drug orforglipron hits key goals in another Phase 3 trial, ...

Eli Lilly said a third late-stage study of its experimental anti-obesity pill hit its key goals, paving the way for the ...

The S&P 500 added 0.4% on Tuesday, Aug. 26, 2025, as investors looked past concerns about President Trump's move to fire a ...